enGene Holdings Inc.
Ownership
Ownership Structure
Who owns enGene Holdings Inc. (ENGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.9% of the shares are freely tradable; institutional investors hold 100.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BML Capital Management LLC | 9.95 | 6,669,908 | +0.0 | 06/30/2026 |
| Siren, L.L.C. | 7.84 | 5,253,159 | +57.5 | 03/31/2026 |
| Perceptive Advisors LLC | 7.20 | 4,822,169 | +0.0 | 06/30/2026 |
| BRAIDWELL LP | 3.67 | 2,456,870 | -21.5 | 03/31/2026 |
| Nextech Invest, Ltd. | 3.47 | 2,324,943 | +0.0 | 06/30/2026 |
| Franklin Templeton Inc | 1.96 | 1,314,993 | -5.3 | 03/31/2026 |
| Polar Capital Holdings PLC | 1.83 | 1,224,071 | +7.1 | 03/31/2026 |
| Balyasny Asset Management LLC | 1.71 | 1,148,997 | +0.0 | 03/31/2026 |
| Peapod Lane Capital LLC | 1.64 | 1,102,149 | +0.0 | 06/30/2026 |
| Millennium Management LLC | 1.44 | 966,627 | +0.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Grossman William | Interim Chief Medical Officer | 5,102 | 10,204 $ | Sep 22, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Grossman William | Interim Chief Medical Officer | Buy | 5,102 | 1.97 | 10,051 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.